Research Faculty

NEED PHOTO

Chao-Yie Yang, Ph.D.
Research Assistant Professor

chaoyie@umich.edu
Phone: 734-764-2449

Campus address:
Department of Internal Medicine
Division of Hematology/Oncology
2049 Palmer Commons
100 Washtenaw Ave
Ann Arbor, MI 48109

Research Interests

Drug Design, Structural Biology, Protein Dynamics, Cancer Biology, Chemical Reaction Kinetics and Dynamics.

Education and Training

1987 B.S., Chemistry, National Taiwan University, Taipei, Taiwan
1996 Ph.D., Physical Chemistry, Case Western Reserve University, Cleveland, OH
1996-1998 Postdoctoral Fellow, Gas Phase Chemical Dynamics Simulation, Argonne National Laboratory, Chicago, IL
1998-2001 Postdoctoral Fellow, Condensed Phase Chemical Dynamics Simulation, University of Texas at Austin, Austin, Tx
2001-2003 Postdoctoral Fellow, Biomedical Sciences, University of Michigan, Ann Arbor, MI

Honors & Awards

1992 Outstanding Teaching Assistant Award, Department of Chemistry, Case Western Reserve University
1993 Alumni Fellowship for Graduate Students, Department of Chemistry, Case Western Reserve University
1993 Graduate Dean's Instructional Excellence Award, Case Western Reserve University
1998-1999 NSF Computation and Information Sciences and Engineering Postdoctoral Fellowship, NSF


Selected Peer Reviewed Publications (2008-present)

  1. Tang G, Nikolovska-Coleska Z, Qiu S, Yang CY, Guo J, Wang S. Acylpyrogallols as inhibitors of antiapoptotic Bcl-2 proteins. J Med Chem, 2008 Feb 28; 51(4):717-720. (PMID 18237106).

  2. Nikolovska-Coleska Z, Meagher JL, Jiang S, Yang CY, Qiu S, Roller PP, Stuckey JA, Wang S. Interaction of a cyclic, bivalent smac mimetic with the x-linked inhibitor of apoptosis protein. Biochemistry, 2008 Sep 16; 47(37):9811-9824. (PMID 18717598) PMC 2784912.

  3. Chen J, Collins GT, Zhang J, Yang CY, Levant B, Woods J, Wang S. Design, synthesis, and evaluation of potent and selective ligands for the dopamine 3 (D3) receptor with a novel in vivo behavioral profile. J Med Chem, 2008 Oct 9; 51(19):5905-5908. (PMID 18785726)  PMC 2662387.

  4. Sun H, Nikolovska-Coleska Z, Yang CY, Qian D, Lu J, Qiu S, Bai L, Peng Y, Cai Q, Wang S. Design of small-molecule peptidic and nonpeptidic Smac mimetics. Acc Chem Res, 2008 Oct; 41(10):1264-1277. (PMID 18937395)  PMC 2676167.

  5. Sun H, Stuckey JA, Nikolovska-Coleska Z, Qin D, Meagher JL, Qiu S, Lu J, Yang CY, Saito NG, Wang S. Structure-based design, synthesis, evaluation, and crystallographic studies of conformationally constrained Smac mimetics as inhibitors of the X-linked inhibitor of apoptosis protein (XIAP). J Med Chem, 2008 Nov 27; 51(22):7169-7180. (PMID 18954041) PMC 2688463.

  6. Peng Y, Sun H, Nikolovska-Coleska Z, Qiu S, Yang CY, Lu J, Cai Q, Yi H, Kang S, Yang D, Wang S. Potent, orally bioavailable diazabicyclic small-molecule mimetics of second mitochondria-derived activator of caspases. J Med Chem, 2008 Dec 25; 51(24):8158-8162. (PMID 19049347)  PMC 2679375.

  7. Zhang B, Nikolovska-Coleska Z, Zhang Y, Bai L, Qiu S, Yang CY, Sun H, Wang S, Wu Y. Design, synthesis, and evaluation of tricyclic, conformationally constrained small-molecule mimetics of second mitochondria-derived activator of caspases. J MedChem, 2008 Dec 11; 51(23):7352-7355. (PMID 19012392)  PMC 2662380.

  8. Sun W, Nikolovska-Coleska Z, Qin D, Sun H, Yang CY, Bai L, Qiu S, Wang Y, Ma D, Wang S. Design, synthesis, and evaluation of potent, nonpeptidic mimetics of second mitochondria-derived activator of caspases. J Med Chem, 2009 Feb 12; 52(3):593-596. (PMID 19138149) PMC 2795317.

  9. Yang CY, Sun H, Chen J, Nikolovska-Coleska Z, Wang S. Importance of ligand reorganization free energy in protein-ligand binding-affinity prediction. J Am Chem Soc, 2009 Sep 30; 131(38):13709-13721. (PMID 19736924)  PMC 2773700.

  10. Sun H, Liu L, Lu J, Qiu S, Yang CY, Yi H, Wang S. Cyclopeptide Smac mimetics as antagonists of IAP proteins. Bioorg Med Chem Lett, 2010 Apr 3. (PMID 20456952).

  11. Sun H, Liu L, Lu J, Qiu S, Yang CY, Yi H, Wang S. Cyclopeptide Smac mimetics as antagonists of IAP proteins. Bioorg Med Chem Lett, 2010 May 15; 20(10):3043-3046. (PMID 20443226) PMC 2997469.

  12. Sun H, Lu J, Liu L, Yi H, Qiu S, Yang CY, Deschamps JR, Wang S. Nonpeptidic and potent small-molecule inhibitors of cIAP-1/2 and XIAP proteins. J Med Chem, 2010 Sep 9; 53(17):6361-6367. (PMID 20684551)  PMC 2936695.

  13. Yang C-Y, Wang S. Computational Analysis of Protein Hotspots. ACS Med Chem Letters, 2010 2010/06/10; 1(3):125-129.

  14. Zhao Y, Lu X, Yang CY, Huang Z, Fu W, Hou T, Zhang J. Computational modeling toward understanding agonist binding on dopamine 3. J Chem Inf Model, 2010 Sep 27; 50(9):1633-1643. (PMID 20695484).

  15. Cai Q, Sun H, Peng Y, Lu J, Nikolovska-Coleska Z, McEachern D, Liu L, Qiu S, Yang C-Y, Miller R, Yi H, Zhang T, Sun D, Kang S, Guo M, Leopold L, Yang D, Wang S. A potent and orally active antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in clinical development for cancer treatment. J  Med Chem, 2011; 54(8):2714-2726. (PMID 21443232).

  16. Yang C-Y, Wang S. Hydrophobic Binding Hot Spots of Bcl-xL Protein−Protein Interfaces by Cosolvent Molecular Dynamics Simulation. ACS Med Chem Letters, 2011 2011/04/14; 2(4):280-284.

  17. Sun H, Liu L, Lu J, Bai L, Li X, Nikolovska-Coleska Z, McEachern D, Yang CY, Qiu S, Yi H, Sun D, Wang S. Potent bivalent Smac mimetics: effect of the linker on binding to inhibitor of apoptosis proteins (IAPs) and anticancer activity. J Med Chem, 2011 May 12; 54(9):3306-3318. (PMID 21462933)  PMC 3108148.

  18. Dunbar JB, Jr., Smith RD, Yang CY, Ung PM, Lexa KW, Khazanov NA, Stuckey JA, Wang S, Carlson HA. CSAR benchmark exercise of 2010: selection of the protein-ligand complexes. J Chem Inf Model, 2011 Sep 26; 51(9):2036-2046. (PMID 21728306)  PMC 3180202.

  19. Smith RD, Dunbar JB, Jr., Ung PM, Esposito EX, Yang CY, Wang S, Carlson HA. CSAR benchmark exercise of 2010: combined evaluation across all submitted scoring functions. J Chem Inf Model, 2011 Sep 26; 51(9):2115-2131. (PMID 21809884)  PMC 3186041.

  20. Peng Y, Sun H, Lu J, Liu L, Cai Q, Shen R, Yang CY, Yi H, Wang S. Bivalent Smac mimetics with a diazabicyclic core as highly potent antagonists of XIAP and cIAP1/2 and novel anticancer agents. J Med Chem, 2012 Jan 12; 55(1):106-114. (PMID 22148838).

  21. Kawamoto SA, Coleska A, Ran X, Yi H, Yang CY, Wang S. Design of triazole-stapled BCL9 alpha-helical peptides to target the beta-catenin/B-cell CLL/lymphoma 9 (BCL9) protein-protein interaction. J Med Chem, 2012 Feb 9; 55(3):1137-1146. (PMID 22196480)  PMC 3286869.

  22. Bai L, McEachern D, Yang CY, Lu J, Sun H, Wang S. LRIG1 modulates cancer cell sensitivity to Smac mimetics by regulating TNFalpha expression and receptor tyrosine kinase signaling. Cancer Res, 2012 Mar 1; 72(5):1229-1238. (PMID 22241084)  PMC 3294058.

  23. Yang C-Y, Wang S. Analysis of Flexibility and Hotspots in Bcl-xL and Mcl-1 Proteins for the Design of Selective Small-Molecule Inhibitors. ACS Med Chem Letters, 2012 2012/04/12; 3(4):308-312.

  24. Zhou H, Chen J, Meagher JL, Yang CY, Aguilar A, Liu L, Bai L, Cong X, Cai Q, Fang X, Stuckey JA, Wang S. Design of Bcl-2 and Bcl-xL inhibitors with subnanomolar binding affinities based upon a new scaffold. J Med Chem, 2012 May 24; 55(10):4664-4682. (PMID 22448988) PMC 3397176.

  25. Zhou H, Aguilar A, Chen J, Bai L, Liu L, Meagher JL, Yang CY, McEachern D, Cong X, Stuckey JA, Wang S. Structure-based design of potent Bcl-2/Bcl-xL inhibitors with strong in vivo antitumor activity. J Med Chem, 2012 Jul 12; 55(13):6149-6161. (PMID 22747598)  PMC 3417242.

  26. Aguilar A, Zhou H, Chen J, Liu L, Bai L, McEachern D, Yang CY, Meagher J, Stuckey J, Wang S. A potent and highly efficacious Bcl-2/Bcl-xL inhibitor. J Med Chem, 2013 Apr 11; 56(7):3048-3067. (PMID 23448298).

Updated Oct 2014